10 unknown, 4 completed, 4 terminated. 12 Phase 2, 6 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Unknown 8, Completed 2, Terminated 2 |
| Phase 1 | 6 | Unknown 3, Completed 2, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow tesetaxel: new trials by email Literature Review of tesetaxel trials Research Report on tesetaxel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors Tesetaxel, Itraconazole, Rifampin - Advanced Solid Tumors | Phase 1 | Terminated | Odonate Therapeutics, Inc. | 93 | 2020-03-06 | 2021-07-28 |
| Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC Tesetaxel, Nivolumab, Pembrolizumab - Breast Cancer | Phase 2 | Terminated | Odonate Therapeutics, Inc. | 294 | 2019-07-09 | 2021-07-30 |
| Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC Tesetaxel, Capecitabine - Breast Cancer | Phase 2 | Terminated | Odonate Therapeutics, Inc. | 152 | 2019-02-05 | 2021-07-30 |
| Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC Tesetaxel and Capecitabine, Capecitabine - Breast Cancer | Phase 3 | Terminated | Odonate Therapeutics, Inc. | 685 | 2017-12-21 | 2021-07-30 |
| Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer Tesetaxel, Capecitabine - Locally Advanced Non-resectable Breast Cancer, Metastatic Breast Cancer | Phase 2 | Unknown | Genta Incorporated | 213 | 2012-05-01 | 2012-06-01 |
| Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer Tesetaxel, Placebo, Capecitabine - Gastric Carcinoma | Phase 2 | Unknown | Genta Incorporated | 580 | 2012-04-01 | 2012-07-24 |
| Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer Tesetaxel-capecitabine-cisplatin - Gastric Carcinoma | Phase 1 / Phase 2 | Unknown | Genta Incorporated | 63 | 2011-05-01 | 2012-03-13 |
| Study of Tesetaxel in Japanese Patients With Solid Tumors Tesetaxel - Advanced Solid Tumors | Phase 1 | Unknown | Genta Incorporated | 12 | 2011-04-01 | 2012-03-13 |
| A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors Tesetaxel plus capecitabine - Solid Tumor | Phase 1 | Unknown | Genta Incorporated | 9 | 2011-03-01 | 2012-07-24 |
| Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer Tesetaxel - Prostate Cancer | Phase 2 | Unknown | Genta Incorporated | 57 | 2011-02-01 | 2012-07-24 |
| Tesetaxel as First-line Therapy for Metastatic Breast Cancer Tesetaxel once every 3 weeks, Tesetaxel once weekly - Breast Neoplasm | Phase 2 | Unknown | Genta Incorporated | 81 | 2010-11-01 | 2012-07-24 |
| Tesetaxel for Previously Treated Patients With Bladder Cancer Tesetaxel - Carcinoma, Transitional Cell | Phase 2 | Unknown | Genta Incorporated | 33 | 2010-09-01 | 2012-07-11 |
| Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules Tesetaxel 10 mg with and then without food, Tesetaxel 10 mg without and then with food - Solid Tumors | Phase 1 | Completed | Genta Incorporated | 12 | 2010-06-01 | 2012-07-24 |
| Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer Tesetaxel - Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction | Phase 2 | Unknown | Genta Incorporated | 27 | 2010-03-01 | 2012-03-15 |
| Phase II Study of Tesetaxel in Metastatic Melanoma Tesetaxel - Advanced Melanoma, Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 17 | 2010-02-01 | 2018-07-17 |
| Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH Tesetaxel - Melanoma | Phase 2 | Unknown | Genta Incorporated | 27 | 2010-02-01 | 2011-11-08 |
| DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors DJ-927, capecitabine - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Daiichi Sankyo | 2004-02-01 | 2012-05-16 | |
| DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma DJ-927 - Colorectal Cancer | Phase 2 | Completed | Daiichi Sankyo | 2004-02-01 | 2012-05-16 |
Breast Neoplasms (5) · Neoplasm Metastasis (3) · Melanoma (2) · Stomach Neoplasms (2) · Carcinoma, Transitional Cell (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Rectal Neoplasms (1) · Triple Negative Breast Neoplasms (1) · Urinary Bladder Neoplasms (1)
Genta Incorporated (11) · Odonate Therapeutics, Inc. (4) · Daiichi Sankyo (2) · M.D. Anderson Cancer Center (1)
United States (16) · South Korea (5) · Taiwan (3) · Australia (2) · Canada (2) · Germany (2) · Italy (2) · Singapore (2) · Spain (2) · Austria (1) · Belgium (1) · Czechia (1) · France (1) · Hungary (1) · Japan (1)
Andrew D Seidman, MD (2) · Jaffer Ajani, MD (2) · Joseph O'Connell, M.D. (2) · Joseph O'Connell, MD (2) · Agop Y Bedikian, MD (1) · Agop Y. Bedikian, MD, BS (1) · Chris H. Takimoto, MD, PhD, FACP (1) · Dean F Bajorin, MD (1) · Harry W Alcorn, PharmD (1) · Lee S Schwartzberg, MD, FACP (1) · Michael J Morris, MD (1) · Peter Cheverton, MD, ChB, MMED, RadT (1) · Sun Young Rha, MD, PhD (1)